期刊文献+

脑星型细胞瘤中CD105、SKP2表达及临床意义 被引量:1

The expression of CD105 and SKP2 in astrocytoma of brains and its clinical significance
下载PDF
导出
摘要 目的探讨细胞膜糖蛋白(CD105)和S期激酶相关蛋白2(SKP2)在脑星型细胞肿瘤组织中的表达及其临床意义。方法应用免疫组化方法检测不同级别120例脑中枢神经系统星型细胞瘤组织与25例正常人脑组织中CD105,SKP2蛋白的表达情况及相关性。结果 CD105蛋白标记的MVD在正常脑组织不表达,在各级别肿瘤细胞中表达阳性,并有逐级升高的趋势,各组之间的差异与病理分级密切相关(P<0.01)。Skp2在正常脑组织基本不表达,在肿瘤细胞中表达阳性,随病理分级逐渐升高,各组比较差异有统计学意义(P<0.01)。二者表达水平呈正相关。SKP2在肿瘤组织中的血管内皮细胞及血管周围也有阳性表达。结论 CD105,SKP2表达阳性率都随肿瘤恶性进展增强,SKP2在血管内皮细胞及周围也有阳性表达;提示在脑中枢神经系统星型细胞瘤中,二者的表达变化与肿瘤的恶性发展、血管生成方面有密切相关,有可能有协同作用。 Objective This paper aims to find the expression and clinical significance of Endoglin (CD105) and S-phase kinase-associated protein 2 (Skp2) in astrocytoma of brains. Methods Immunohistoehemistry was used to detect CD105 and SKP2 protein expression and the correlation in different levels of 120 human astrocytoma tissues and 25 normal brain tissues. Results Mierovessel density (MVD) marked by CD105 protein did not express in normal brain tissue but it was expressed positively at all levels of astroeytoma. The positive percentage was gradually increased with the pathological grade and they were also closely correlated (P 〈 0.01 ). Skp2 expression in normal brain tissue was not obvious. The expression in astrocytoma tissues was also gradually increased with pathological grade and they were also correlated (P 〈 0.05 ) with significant statistical differences ( P 〈 0.01 ). Skp2 also expressed positive in tumor tissue vascular endothelial cells and perivascular tissnes. Conclusion CD105 and SKP2 expression rates are enhanced with the malignant progression of tumors, and vascular endothelial cells are positive expressed. It prompts that the expression changes of CD105 and SKP2 in the human brain astrocytoma are closely related with the development of malignant tumors and angiogenesis. There may be a synergistic effect.
出处 《中华神经外科疾病研究杂志》 CAS 2016年第3期221-224,共4页 Chinese Journal of Neurosurgical Disease Research
  • 相关文献

参考文献10

  • 1Shuangshoti S, Thorner PS, Ruangvejvoraehai P, et al. J1-31 protein expression in astroeytes and astroeytomas [J]. Neuropathology, 2009,29(5) : 521 -527.
  • 2Nyberg P, Salo T, Kalluri R. Tumor microenvironment and angiogenesis [ J]. Front Biosci, 2008, 13:6537-6553.
  • 3Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer [J]. Cancer, 2008, 112(7) : 1415 -1424.
  • 4Smith SJ, Tilly H, Ward JH, et al. CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma [J]. Acta Neuropathol, 2012, 124(1 ): 99- 110.
  • 5郭欣茹,张剑宁,刘爽,王淑为,于雪,刘兵.中枢神经系统星形细胞瘤中MGMT,STAT-3表达及临床意义[J].中华神经外科疾病研究杂志,2014,13(3):245-248. 被引量:1
  • 6Netto GC, Bleil CB, Hilbig A, et al. Immuno-histochemical evaluation of the mierovascular density through the expression of TGF-BETA (CD105/ENdoglin) and CD34 receptors and expression of the vascular endothelial growth factor ( VEGF ) in oligodendrogliomas [ J ]. Neuropathology, 2008, 28( 1 ) : 17 -23.
  • 7Seon BK, Haba A, Matsuno F, et al. Endoglin-targeted cancer therapy [J]. CurrDrugDeliv, 2011, 8 (1): 135 -143.
  • 8Radhakrishna R, Ha JH, Dhanasekaran DN. Mitogenic signaling by the gep oncogene involves the upregulation of s-phase kinase-associated protein 2 [J]. Genes Cancer, 2010, 1(10) : 1033- 1043.
  • 9Galeano F, Rossetti C, Tomaselli S, et al. ADAR2-editing activity inhibits glioblastoma growth through the modulation of theCDCI4B! Skp2/p21/p27 axis [J3. Oncogene, 2013, 32(8): 998- 1009.
  • 10尹丰,田增民,刘爽,王亚明,李志超,惠瑞,郭欣茹,于雪,张剑宁.S期激酶相关蛋白2在胶质瘤中的表达及临床意义[J].解放军医学杂志,2012,37(9):855-858. 被引量:1

二级参考文献14

  • 1刘爽,田增民,郑国强,吴海涛,靳燕彬,马鑫,范文红,范明.脑胶质瘤相关新基因表达的微阵列基因芯片分析[J].中华医学遗传学杂志,2007,24(2):182-185. 被引量:3
  • 2Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer[J]. Cancer, 2008, 112(7): 1415-1424.
  • 3Langner C, yon Wasielewski R, Ratschek M, et al. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic turnout tissues using a tissue microarray technique[J]. Virchows Arch, 2004, 445(6): 631-636.
  • 4Langner C, yon Wasielewski R, Ratschek M, et al. Expression of p27 and its ubiquitin ligase subunit Skp2 inupper urinary tract transitional cell carcinoma[J]. Urology, 2004, 64(3): 611-616.
  • 5Yang G, Ayala G, De Marzo A, et al. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival[J]. Clin Cancer Res, 2002, 8(11): 3419-3426.
  • 6Lim MS, Adamson A, Lin Z, et al. Expression of Skp2, a p27 (Kip 1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kipl) and proliferation index[J]. Blood, 2002, 100(8):2950-2956.
  • 7Shapira M, Ben-Izhak O, Linn S, et al. The prognostic impact of the ubiquitin ligase subunits Skp2 and Ckslin colorectal carcinoma[J]. Cancer, 2005, 103(7): 1336-1346.
  • 8Sutterluty H, Chatelain Ej Marti A- et al. p4SSKP2 promotes p27Kip 1degradation and induces S phase in quiescent cells[J]. Nat Cell Biol, 1999, 1(4): 207-214.
  • 9Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF- type ubiquitin ligases[J]. Semin Cell Dev Biol, 2005, 16(3): 323-333.
  • 10Nakayama KI, Hatakeyama S, Nakayama K. Regulation of the cell cycle at the G--S transition by proteolysis of cyclin E and p27Kipl [J], Biochem Biophys Res Commun, 2001, 282(4): 853-860.

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部